Glycopyrronium · Medicine question

What condition is Seebri Breezhaler (glycopyrronium) licensed to treat in adults?

Name: What condition is Seebri Breezhaler (glycopyrronium) licensed to treat in adults?
Published: 2026-11-08T01:31:08.590Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Seebri Breezhaler (glycopyrronium) is licensed as maintenance bronchodilator treatment to relieve symptoms in adults with chronic obstructive pulmonary disease (COPD).

Sources for this answer

Seebri Breezhaler Inhalation Powder, Hard Capsules 44mcgNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated 15 July 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about Glycopyrronium